HG Stock Analysis: Hamilton Insurance | NYSE
Insurance - Reinsurance | NYSE, USA | Market Cap: 3.418m USD | 12M Return: 75% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.8M
Qual. Beats: 5
Rev. Trend: 93.1%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 2.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hamilton Insurance Group, Ltd. (NYSE: HG) is a Bermuda-based specialty insurance and reinsurance company operating internationally through three underwriting platforms: Hamilton Global Specialty, Hamilton Select, and Hamilton Re. The company provides a broad range of casualty, property, and specialty reinsurance and insurance products spanning lines such as aviation, marine and energy, cyber, political risk, professional liability, and accident and health. Founded in 2013 and headquartered in Pembroke, Bermuda, Hamilton went public in November 2023.
As a specialty insurer and reinsurer, Hamilton focuses on complex or higher-severity risks that standard carriers often avoid, underwriting coverage through both treaty and facultative arrangements. Bermuda has long served as one of the worlds leading hubs for insurance and reinsurance, offering a favorable regulatory and tax environment that has attracted major global players in the industry.
- Catastrophe losses from hurricanes and wildfires pressure underwriting results
- Reinsurance pricing trends in specialty lines drive premium growth
- Investment income expands on higher rates and growing float
| Net Income: 629.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 19.27% < 20% (prev 33.63%; Δ -14.36% < -1%) |
| CFO/TA 0.09 > 3% & CFO 908.3m > Net Income 629.3m |
| Net Debt (-2.72b) to EBITDA (895.1m): -3.04 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 49.49% > 18% (prev 37.87%; Δ 11.62% > 0.5%) |
| Asset Turnover: 31.84% > 50% (prev 24.34%; Δ 7.50% > 0%) |
| Interest Coverage Ratio: 45.40 > 6 (EBIT TTM 879.2m / Interest Expense TTM 19.4m) |
| A: 0.06 (Total Current Assets 7.52b - Total Current Liabilities 6.96b) / Total Assets 9.86b |
| B: 0.16 (Retained Earnings 1.60b / Total Assets 9.86b) |
| C: 0.10 (EBIT TTM 879.2m / Avg Total Assets 9.10b) |
| D: 0.38 (Book Value of Equity 2.72b / Total Liabilities 7.11b) |
| Altman-Z'' = 1.95 = BBB |
| DSRI: 0.79 (Receivables 2.68b/2.36b, Revenue 2.90b/2.03b) |
| GMI: 0.77 (GM 37.87% / 49.49%) |
| AQI: 1.04 (AQ_t 0.24 / AQ_t-1 0.23) |
| SGI: 1.43 (Revenue 2.90b / 2.03b) |
| TATA: -0.03 (NI 629.3m - CFO 908.3m) / TA 9.86b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at USD 34.49 with a total of 520,657 shares traded. Over the past week, the price has changed by +1.62%, over one month by +13.04%, over three months by +10.94% and over the past year by +75.00%.
Current recommended Stop Loss: 33.30 (which is 3.5% or 1.4 ATR below the current price).
Hamilton Insurance has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy HG.
- StrongBuy: 1
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 34.1 | -1% |
P/E Trailing = 5.6552
P/S = 1.181
P/B = 1.2316
Revenue TTM = 2.90b USD
EBIT TTM = 879.2m USD
EBITDA TTM = 895.1m USD
Long Term Debt = 149.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 149.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.72b USD (calculated: Debt 149.8m - CCE 2.87b)
Enterprise Value = 695.9m USD (3.42b + Debt 149.8m - CCE 2.87b)
Interest Coverage Ratio = 45.40 (Ebit TTM 879.2m / Interest Expense TTM 19.4m)
EV/FCF = 0.83x (Enterprise Value 695.9m / FCF TTM 836.5m)
FCF Yield = 120.2% (FCF TTM 836.5m / Enterprise Value 695.9m)
FCF Margin = 28.86% (FCF TTM 836.5m / Revenue TTM 2.90b)
Net Margin = 21.71% (Net Income TTM 629.3m / Revenue TTM 2.90b)
Gross Margin = 49.49% ((Revenue TTM 2.90b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 56.95% (prev 55.56%)
Tobins Q-Ratio = 0.07 (Enterprise Value 695.9m / Total Assets 9.86b)
Interest Expense / Debt = 12.93% (Interest Expense 19.4m / Debt 149.8m)
Taxrate = 1.06% (2.32m / 219.4m)
NOPAT = 869.8m (EBIT 879.2m * (1 - 1.06%))
Current Ratio = 0.99 (Total Current Assets 7.52b / Total Current Liabilities 7.57b)
Debt / Equity = 0.06 (Debt 149.8m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -3.04 (Net Debt -2.72b / EBITDA 895.1m)
Debt / FCF = -3.25 (Net Debt -2.72b / FCF TTM 836.5m)
Total Stockholder Equity = 2.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.91% (Net Income 629.3m / Total Assets 9.86b)
RoE = 23.38% (Net Income TTM 629.3m / Total Stockholder Equity 2.69b)
RoCE = 30.94% (EBIT 879.2m / Capital Employed (Equity 2.69b + L.T.Debt 149.8m))
RoIC = 31.54% (NOPAT 869.8m / Invested Capital 2.76b)
WACC = 8.53% (E(3.42b)/V(3.57b) * Re(8.34%) + D(149.8m)/V(3.57b) * Rd(12.93%) * (1-Tc(0.01)))
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.03 | Cagr: -3.61%
[DCF] Terminal Value 77.40% ; FCFF base≈727.5m ; Y1≈834.0m ; Y5≈1.23b
[DCF] Fair Price = 310.2 (EV 17.9b - Net Debt -2.72b = Equity 20.6b / Shares 66.5m; r=8.53% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.40 | # QB: 5
Revenue Correlation: 93.07 | Revenue CAGR: 33.57% | SUE: 1.98 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.18 | Chg30d=+3.65% | Revisions=-29% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=+0.07% | Revisions=+25% | Analysts=6
EPS current Year (2026-12-31): EPS=4.57 | Chg30d=+0.53% | Revisions=+30% | GrowthEPS=-5.5% | GrowthRev=-5.3%
EPS next Year (2027-12-31): EPS=4.70 | Chg30d=+0.01% | Revisions=+17% | GrowthEPS=+2.8% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: +17% (up=9, down=6)